AstraZeneca Pharma India Limited (BOM:506820)
6,930.80
-16.15 (-0.23%)
At close: Sep 4, 2026
AstraZeneca Pharma India Company Description
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
It provides medicines for cancers, including pancreatic cancer, certain blood cancers, and cancers within breast, lung, ovary, and prostate; rare diseases; and cardiovascular, renal and metabolism, and respiratory and immunology, as well as diabetes.
The company serves distributors, hospitals, and government institutions. The company was incorporated in 1979 and is based in Bengaluru, India.
AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
AstraZeneca Pharma India Limited
| Country | India |
| Founded | 1979 |
| Industry | Pharmaceutical Preparations |
| Employees | 600 |
| CEO | Praveen Akkinepally |
Contact Details
Address: Manyata Embassy Business Park Bengaluru, 560045 India | |
| Phone | 91 80 6774 8000 |
| Website | astrazeneca.in |
Stock Details
| Ticker Symbol | 506820 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Praveen Akkinepally | Chief Executive Officer |